Anchor Therapeutics

Targeted small peptide therapeutics for metabolic and cardiovascular diseases.

placeCambridge, Massachusetts, United States calendar_todayFounded 2006 groups3 employees language anchortx.com

Registered entities

Innovation

8 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 264 times.

YearFilings
20134
20143
20155
20161
20181
20191

Investor mix

5 investors on record; lead investors include TVM Capital, Healthcare Ventures, Novartis, HealthCare 365.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon